Targeting Completion in December 2026

Yuhan Pharmaceutical announced on the 19th that it held a groundbreaking ceremony for its new factory at Osong 2nd Life Science Complex (688, Jeongjung-ri, Osong-eup, Cheongju, Chungbuk) on the 18th. The event was attended by key figures, including executives and employees of Yuhan Pharmaceutical, as well as representatives from Bumil Construction, the construction company.

Hanyang Pharmaceutical held a groundbreaking ceremony for its new factory on the 18th at Osong 2nd Life Science Complex in Osong-eup, Jeongjung-ri 688, Cheongju, Chungbuk. From the left in the photo are Kalyongseon, Vice President of Donghwa; Heejung Jang, CEO of Jeonin Construction Management; Jaecheon Yoo, Vice President and Head of Pharmaceutical Business Division at Yuhan Pharmaceutical; Yeolhong Kim, President of R&D at Yuhan Pharmaceutical; Wookje Cho, CEO and President of Yuhan Pharmaceutical; Byungman Lee, Vice President and Head of Management Division at Yuhan Pharmaceutical; Daesik Kang, Executive Director and Head of Production Division at Yuhan Pharmaceutical; Byungdeok Seol, CEO of Bumil Construction; and Minja Lee, CEO of Byeokjin Architecture Office, posing for a commemorative photo at the groundbreaking ceremony. Yuhan Pharmaceutical

Hanyang Pharmaceutical held a groundbreaking ceremony for its new factory on the 18th at Osong 2nd Life Science Complex in Osong-eup, Jeongjung-ri 688, Cheongju, Chungbuk. From the left in the photo are Kalyongseon, Vice President of Donghwa; Heejung Jang, CEO of Jeonin Construction Management; Jaecheon Yoo, Vice President and Head of Pharmaceutical Business Division at Yuhan Pharmaceutical; Yeolhong Kim, President of R&D at Yuhan Pharmaceutical; Wookje Cho, CEO and President of Yuhan Pharmaceutical; Byungman Lee, Vice President and Head of Management Division at Yuhan Pharmaceutical; Daesik Kang, Executive Director and Head of Production Division at Yuhan Pharmaceutical; Byungdeok Seol, CEO of Bumil Construction; and Minja Lee, CEO of Byeokjin Architecture Office, posing for a commemorative photo at the groundbreaking ceremony. Yuhan Pharmaceutical

View original image

The new Yuhan Pharmaceutical factory will have a total floor area of 16,593.51 square meters (approximately 5,019.5 pyeong), consisting of one basement floor and three above-ground floors. The completion is targeted for December 2026, and the facility will be equipped with advanced manufacturing lines capable of producing up to 700 million oral solid tablets annually.


The new manufacturing facility at Osong 2nd Life Science Complex aims to maximize production efficiency by leveraging its connection with the existing Ochang plant. Through this, the Yuhan Pharmaceutical Osong New Factory is expected to establish itself as a strategic hub that can expand collaboration opportunities with both domestic and international pharmaceutical companies.

Perspective View of Yuhan Corporation Osong New Factory

Perspective View of Yuhan Corporation Osong New Factory

View original image

The Osong New Factory has been designed to maximize production efficiency and quality by applying state-of-the-art automation systems and precise environmental control technologies that meet global quality standards. As a next-generation production facility equipped with a smart manufacturing environment, it is expected to become a core infrastructure driving Yuhan Pharmaceutical’s future growth.


Hot Picks Today


A Yuhan Pharmaceutical representative stated, "The Osong New Factory has been designed to meet advanced Good Manufacturing Practice (GMP) standards in terms of quality and production," adding, "It is expected to play an important role in the company's future growth and strengthening of competitiveness."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing